Speciality Medicines – IPO
Speciality Medicines – IPO Details
| IPO Date | March 20, 2026 to March 24, 2026 |
| Listing Date | April 30, 2026 |
| Face Value | ₹ 10 / Share |
| Price Band | ₹ 117 to ₹ 124 / Share |
| Lot Size | 1000 Shares |
| Total Issue Size | 23,50,000 (Aggregating up to ₹29 Cr) |
| Fresh Issue | 22,00,000 (Aggregating up to ₹27 Cr) |
| Offer for Sale | |
| Employee Discount | |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share holding pre issue | 64,35,796 |
| Share holding post issue | 87,85,796 |
| Market Maker portion | 1,50,000 |
Speciality Medicines Timeline (Tentative Schedule)
Speciality Medicines IPO opens on March 20, 2026, and closes on March 24, 2026.
| IPO Open Date | March 20, 2026 |
| IPO Close Date | March 24, 2026 |
| Basis of Allotment | March 25, 2026 |
| Initiation of Refunds | March 27, 2026 |
| Credit of Shares to Demat | March 27, 2026 |
| Listing Date | April 30, 2026 |
| Cut-off time for UPI mandate confirmation | March 24, 2026 |
Speciality Medicines IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | Rs.248,000 |
| Retail (Max) | 2 | 2,000 | Rs.248,000 |
| S-HNI (Min) | 3 | 3,000 | Rs.372,000 |
| S-HNI (Max) | 8 | 8,000 | Rs.992,000 |
| B-HNI (Min) | 9 | 9,000 | Rs.1,116,000 |
| HNI (Min) |
Speciality Medicines IPO Promoter Holding
| Share Holding Pre Issue | 64,35,796 |
| Share Holding Post Issue | 87,85,796 |
Speciality Medicines IPO Reservation
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | |
|
| Market Maker Shares Offered | |
|
| Other Shares Offered | |
|
| QIB Shares Offered | Not more than 2% of the Net Issue |
|
| NII (HNI) Shares Offered | Not less than 49% of Net Issue |
|
| bNII > ₹10L | |
|
| sNII < ₹10L | |
|
| Retail Shares Offered | Not less than 49% of Net Issue |
|
| Employee Shares Offered | |
|
| Total Shares Offered | |
Speciality Medicines IPO Anchor Investors Details
| Bid Date | |
| Shares Offered | |
| Anchor Portion Size (In Cr.) | |
| Anchor lock-in period end date for 50% shares (30 Days) | |
| Anchor lock-in period end date for remaining shares (90 Days) |
About Speciality Medicines
Speciality Medicines Limited was established in 2021 and is involved in the marketing and distribution of completed specialty pharmaceutical formulations, including expensive oral and injectable drugs used to treat complicated chronic illnesses, in both domestic and foreign markets.
A variety of specialty pharmaceutical finished formulations products, including tablets, capsules, creams, syrups, eye drops, gels, infusions, inhalers, injections, nasal sprays, ointments, ophthalmic solutions, oral solutions, sachets, and suspensions, are offered in the company's portfolio.
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 37.85% |
| ROCE | 33.39% |
| Debt/Equity | 0.17 |
| RoNW | 28.30% |
| P/BV | 2.62 |
| PAT Margin (%) | 14.77% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 13.38 | 11.82 |
| P/E (x) | 9.27 | 10.49 |
Objects of the Issue (Speciality Medicines IPO Objectives)
Speciality Medicines Contact Details
Speciality Medicines Limited 913, One World West, S. No. 396, FP 119, Village: Vejalpur, Ahmadabad City, Ahmedabad, Gujarat, India, Ahmedabad, Gujarat, 380051 Phone: +91 22 4604 5344 Email: [email protected] Website: https://www.specialitymedicine.com/ |
Speciality Medicines IPO Registrar
Skyline Financial Services Pvt. Ltd. Phone: 02228511022 Email: [email protected] Website: https://www.skylinerta.com/ipo.php |